Encouraging activity for R-CHOP in advanced stage nodular lymphocyte–predominant Hodgkin lymphoma

Michelle A. Fanale; Chan Y. Cheah; Amy Rich; L. Jeffrey Medeiros; Chao-Ming Lai; Yasuhiro Oki; Jorge Romaguera; Luis Fayad; Fredrick B. Hagemeister; Felipe Samaniego; Maria Alma Rodriguez; Sattva S. Neelapu; Hun Ju Lee; Loretta J. Nastoupil; Nathan Fowler; Francesco Turturro; Jason R. Westin; Michael Wang; Peter McLaughlin; Chelsea C. Pinnix; Sarah A. Milgrom; Bouthaina S. Dabaja; Sandra B. Horowitz; Anas Younes

doi:10.1182/blood-2017-02-766121

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

= .006 and .002, respectively) but not OS. Our data support a potential role for R-CHOP in patients with NLPHL. Larger prospective trials are needed to define the optimal chemotherapy regimen.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fanale et al. (2017) studied this question.

synapsesocial.com/papers/6aa4df8fc19a1092ac8120f8 https://doi.org/10.1182/blood-2017-02-766121

View Full Paper

Ask AI

Bookmark

Share

Encouraging activity for R-CHOP in advanced stage nodular lymphocyte–predominant Hodgkin lymphoma

Ask about this paper

Abstract

Discussion

Cite This Study

Encouraging activity for R-CHOP in advanced stage nodular lymphocyte–predominant Hodgkin lymphoma

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading